Fig. 3From: In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteriaTime-kill curves performed on A. baumannii (A), S. aureus (B), and K. pneumonia (C) treated with 1×MIC (green line), 2×MIC (yellow line), and 4×MIC (red line) doses of melittin peptideBack to article page